Shanghai Pan-Lin Asset Management
Panlin Capital is a venture firm that invests in e-commerce, automotive, biotech and healthcare sectors.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed Shanghai Pan-Lin Asset Management Information
Geographic Data
Address: 1788 , 1800 Century Avenue
City: Pudong
State: shanghai municipality
Zip: 200122
Country: CN
Financial Info
Stage:
Raised Last:
$0
Raised Total:$148M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Panlin Capital is a venture firm that invests in e-commerce, automotive, biotech and healthcare sectors.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2018 | AOSSCI | Series A | - |
| 6/2022 | Yueer Gene | Series B | 0 |
| 7/2019 | Qinheli Biomedical | Seed Round | 8.7M |
| 5/2019 | Chuantu Microelectronics | Series A | - |
| 9/2019 | Antekang Cheng | Seed Round | - |
| 6/2018 | Gongguizhijia | Series A | 3.1M |
| 6/2022 | NuProbe | Series B | 0 |
| 5/2018 | Iris (Integrated Retail Information Solution) | Series A | - |
| 9/2018 | Yesmro | Seed Round | - |
| 1/2020 | Percipio.xyz | Series A | - |
| 3/2021 | Percipio.xyz | Series B | - |
| 12/2019 | Suzhou Ribo Life Science | Series C | 0 |
| 3/2017 | YCloset | Series B | 20M |
| 12/2021 | PPIO | Series A | 0 |
| 1/2019 | Apollomics | Series B | 100M |
| 2/2017 | Percans Oncology | Series B | 7.3M |
| 3/2018 | XGIMI | Corporate Round | 95M |
| 7/2016 | Passiontec | Series A | 1.5M |
| 7/2012 | Dream | Series B | 3.1M |
| 3/2019 | LangRui Medical | Seed Round | - |
| 2/2023 | Zhishan Weixin Biotechnology | Series A | 296.6k |
| 11/2021 | KingstronBio | Series C | 0 |
| 5/2022 | PPIO | Series A | 0 |
| 12/2021 | GenFleet Therapeutics | Series C | 0 |
| 1/2021 | NuProbe | Series B | 0 |
| 12/2021 | Xiaoxiang Zhihe | Series A | 9.4M |
| 8/2019 | Happy Cycle | Seed Round | - |
| 3/2020 | GenFleet Therapeutics | Series B | 57.7M |
| 12/2021 | Xiaoxiang Zhihe | Series A | - |
| 9/2020 | Virogin Biotech | Series C | 62M |
| 3/2017 | Suzhou Ribo Life Science | Series B | 0 |
| 5/2021 | Ruiyun Cold Chain | Angel Round | 18.6M |
| 11/2022 | Ruiyun Cold Chain | Seed Round | 28M |
| 3/2018 | ensenmax | Seed Round | 473.8k |
| 3/2018 | Chuantu Microelectronics | Seed Round | - |
| 1/2020 | Yesmro | Series A | - |
| 9/2019 | Yesmro | Series A | 10M |
| 6/2022 | Yueer Gene | Series B | 0 |
| 6/2022 | NuProbe | Series B | 0 |
| 5/2022 | PPIO | Series A | 0 |
| 12/2021 | GenFleet Therapeutics | Series C | 0 |
| 12/2021 | Xiaoxiang Zhihe | Series A | - |
| 12/2021 | Xiaoxiang Zhihe | Series A | 0 |
| 12/2021 | PPIO | Series A | 0 |
| 11/2021 | KingstronBio | Series C | 0 |
| 5/2021 | Ruiyun Cold Chain | Angel Round | 0 |
| 1/2021 | NuProbe | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2020 | Investment Fund | $147.7M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
